» Articles » PMID: 34544818

Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia

Overview
Journal Neurology
Specialty Neurology
Date 2021 Sep 21
PMID 34544818
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: AP-4-associated hereditary spastic paraplegia (AP-4-HSP: SPG47, SPG50, SPG51, SPG52) is an emerging cause of childhood-onset hereditary spastic paraplegia and mimic of cerebral palsy. This study aims to define the spectrum of brain MRI findings in AP-4-HSP and to investigate radioclinical correlations.

Methods: We performed a systematic qualitative and quantitative analysis of 107 brain MRI studies from 76 individuals with genetically confirmed AP-4-HSP and correlation with clinical findings including surrogates of disease severity.

Results: We define AP-4-HSP as a disorder of gray and white matter and demonstrate that abnormal myelination is common and that metrics of reduced white matter volume correlate with severity of motor symptoms. We identify a common diagnostic imaging signature consisting of (1) a thin splenium of the corpus callosum, (2) an absent or thin anterior commissure, (3) characteristic signal abnormalities of the forceps minor ("ears of the grizzly sign"), and (4) periventricular white matter abnormalities. The presence of 2 or more of these findings has a sensitivity of ∼99% for detecting AP-4-HSP; the combination of all 4 is found in ∼45% of cases. Compared to other HSPs with a thin corpus callosum, the absent anterior commissure appears to be specific to AP-4-HSP. Our analysis identified a subset of patients with polymicrogyria, underscoring the role of AP-4 in early brain development. These patients displayed a higher prevalence of seizures and status epilepticus, many at a young age.

Discussion: Our findings define the MRI spectrum of AP-4-HSP, providing opportunities for early diagnosis, identification of individuals at risk for complications, and a window into the role of the AP-4 complex in brain development and neurodegeneration.

Citing Articles

An update on autophagy disorders.

Dafsari H, Martinelli D, Saffari A, Ebrahimi-Fakhari D, Fanto M, Dionisi-Vici C J Inherit Metab Dis. 2024; 48(1):e12798.

PMID: 39420677 PMC: 11669743. DOI: 10.1002/jimd.12798.


Altered tubulin detyrosination due to SVBP malfunction induces cytokinesis failure and senescence, underlying a complex hereditary spastic paraplegia.

Launay N, Espinosa-Alcantud M, Verdura E, Fernandez-Eulate G, Ondaro J, Iruzubieta P Aging Cell. 2024; 24(1):e14355.

PMID: 39412222 PMC: 11709099. DOI: 10.1111/acel.14355.


Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.

Wiseman J, Scarrott J, Alves-Cruzeiro J, Saffari A, Boger C, Karyka E EMBO Mol Med. 2024; 16(11):2882-2917.

PMID: 39358605 PMC: 11554807. DOI: 10.1038/s44321-024-00148-5.


AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient.

Dowling J, Pirovolakis T, Devakandan K, Stosic A, Pidsadny M, Nigro E Nat Med. 2024; 30(7):1882-1887.

PMID: 38942994 PMC: 11271397. DOI: 10.1038/s41591-024-03078-4.


Imaging Findings and MRI Patterns in a Cohort of 18q Chromosomal Abnormalities.

Malik P, Branson H, Yoon G, Shroff M, Blaser S, Krishnan P AJNR Am J Neuroradiol. 2024; 45(10):1578-1585.

PMID: 38816019 PMC: 11448982. DOI: 10.3174/ajnr.A8361.


References
1.
Behne R, Teinert J, Wimmer M, DAmore A, Davies A, Scarrott J . Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Hum Mol Genet. 2020; 29(2):320-334. PMC: 7001721. DOI: 10.1093/hmg/ddz310. View

2.
Edwards T, Sherr E, Barkovich A, Richards L . Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. Brain. 2014; 137(Pt 6):1579-613. PMC: 4032094. DOI: 10.1093/brain/awt358. View

3.
Ebrahimi-Fakhari D, Saffari A, Wahlster L, Lu J, Byrne S, Hoffmann G . Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism. Brain. 2015; 139(Pt 2):317-37. PMC: 5841365. DOI: 10.1093/brain/awv371. View

4.
Pensato V, Castellotti B, Gellera C, Pareyson D, Ciano C, Nanetti L . Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain. 2014; 137(Pt 7):1907-20. DOI: 10.1093/brain/awu121. View

5.
Ebrahimi-Fakhari D, Saffari A, Pearl P . Childhood-onset hereditary spastic paraplegia and its treatable mimics. Mol Genet Metab. 2021; 137(4):436-444. PMC: 8843241. DOI: 10.1016/j.ymgme.2021.06.006. View